20 May 2013
Keywords: gsk/ligand, promacta, get, fda, priority, review, uk
Article | 10 March 2008
UK drug major GlaxoSmithKline says that the US Food and Drug Administration has granted a priority review for Promacta (eltrombopag)
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 March 2008
17 May 2013
© 2013 thepharmaletter.com